According to ImmunoGen
's latest financial reports the company has C$0.80 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $C$0.21 B | -49.04% |
2021-12-31 | $C$0.41 B | 263.32% |
2020-12-31 | $C$0.11 B | -214.88% |
2019-12-31 | $-C$99.42 Million | -765.18% |
2018-12-31 | $C$14.94 M | -166.43% |
2017-12-31 | $-C$22.5 Million | |
2016-06-30 | $-C$0.11 Billion | -344.33% |
2015-06-30 | $C$43.57 M | -46.03% |
2014-06-30 | $C$80.73 M | -37.01% |
2013-06-30 | $C$0.12 B | 50.06% |
2012-06-30 | $C$85.41 M | -36.92% |
2011-06-30 | $C$0.13 B | 24.87% |
2010-06-30 | $C$0.10 B | 39.57% |
2009-06-30 | $C$77.69 M | 37.84% |
2008-06-30 | $C$56.36 M | -8.95% |
2007-06-30 | $C$61.9 M | -23.24% |
2006-06-30 | $C$80.64 M | -24.17% |
2005-06-30 | $C$0.10 B | -17.88% |
2004-06-30 | $C$0.12 B | -6.36% |
2003-06-30 | $C$0.13 B | -32.02% |
2002-06-30 | $C$0.20 B | -5.72% |
2001-06-30 | $C$0.21 B |